INVESTMENT SECURITIES (Tables)
|
12 Months Ended |
Mar. 31, 2025 |
Debt Securities, Trading, and Equity Securities, FV-NI [Abstract] |
|
Schedule of trading and available-for-sale securities |
As of March 31, 2025 and 2024, trading, held-to-maturity and available-for-sale securities consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
March 31, 2024 |
|
|
|
|
Non-U.S. sovereign debt |
$ |
1,282,450 |
|
|
$ |
2,409,126 |
|
Corporate debt |
807,985 |
|
|
1,108,870 |
|
Corporate equity |
106,227 |
|
|
126,103 |
|
U.S. sovereign debt |
73,787 |
|
|
43,173 |
|
Exchange traded notes |
4,837 |
|
|
1,348 |
|
Total trading securities |
$ |
2,275,286
|
|
|
$ |
3,688,620
|
|
|
|
|
|
Non-US sovereign debt |
208,231 |
|
|
27,016 |
|
Corporate debt |
243,730 |
|
|
173,568 |
|
US sovereign debt |
21,626 |
|
|
16,037 |
|
Total available-for-sale securities, at fair value |
$ |
473,587
|
|
|
$ |
216,621
|
|
|
|
|
|
Non-US sovereign debt |
65,914 |
|
|
— |
|
Allowance for Non-US sovereign debt |
(54) |
|
|
— |
|
Total held-to-maturity securities |
$ |
65,860
|
|
|
$ |
—
|
|
|
|
|
|
Total investment securities |
2,814,733
|
|
|
3,905,241
|
|
|
Schedule of maturity of debt securities |
The following tables present maturity analysis for available-for-sale securities as of March 31, 2025 and March 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
Remaining contractual maturity of the agreements |
|
Up to 1 year |
|
1-5 years |
|
5-10 years |
|
More than 10 years |
|
Total |
|
|
|
|
|
|
|
|
|
|
Non-US sovereign debt |
66,593 |
|
|
96,662 |
|
|
29,136 |
|
|
15,840 |
|
|
208,231 |
|
Corporate debt |
85,300 |
|
|
141,382 |
|
|
9,308 |
|
|
7,740 |
|
|
243,730 |
|
US sovereign debt |
— |
|
|
20,421 |
|
|
— |
|
|
1,205 |
|
|
21,626 |
|
Total available-for-sale securities, at fair value |
$ |
151,893
|
|
|
$ |
258,465
|
|
|
$ |
38,444
|
|
|
$ |
24,785
|
|
|
$ |
473,587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
Remaining contractual maturity of the agreements |
|
Up to 1 year |
|
1-5 years |
|
5-10 years |
|
More than 10 years |
|
Total |
|
|
|
|
|
|
|
|
|
|
Corporate debt |
$ |
65,415 |
|
|
$ |
44,374 |
|
|
$ |
59,553 |
|
|
$ |
4,226 |
|
|
$ |
173,568 |
|
Non-US sovereign debt |
7,839 |
|
|
7,310 |
|
|
5,797 |
|
|
6,070 |
|
|
27,016 |
|
US sovereign debt |
— |
|
|
5,059 |
|
|
9,753 |
|
|
1,225 |
|
|
16,037 |
|
Total available-for-sale securities, at fair value |
$ |
73,254
|
|
|
$ |
56,743
|
|
|
$ |
75,103
|
|
|
$ |
11,521
|
|
|
$ |
216,621
|
|
The following table presents maturity analysis for held-to-maturity securities as of March 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
Remaining contractual maturity of the agreements |
|
Up to 1 year |
|
1-5 years |
|
5-10 years |
|
More than 10 years |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-US sovereign debt |
— |
|
|
— |
|
|
11,931 |
|
|
53,929 |
|
|
65,860 |
|
|
|
|
|
|
|
|
|
|
|
Total held-to-maturity securities |
$ |
—
|
|
|
$ |
—
|
|
|
$ |
11,931
|
|
|
$ |
53,929
|
|
|
$ |
65,860
|
|
|
Schedule of present securities assets at fair value |
The following tables present trading securities assets in the Consolidated Financial Statements or disclosed in the Notes to the Consolidated Financial Statements at fair value on a recurring basis as of March 31, 2025 and March 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average
interest rate
|
|
Total |
|
Fair Value Measurements at
March 31, 2025 using
|
|
|
|
Quoted Prices in Active Markets for Identical Assets |
|
Significant Other Observable Inputs |
|
Significant unobservable units |
|
|
|
(Level 1) |
|
(Level 2) |
|
(Level 3) |
|
|
|
|
|
|
|
|
|
|
Non-U.S. sovereign debt |
11.24 |
% |
|
$ |
1,282,450 |
|
|
$ |
987,657 |
|
|
$ |
294,793 |
|
|
$ |
— |
|
Corporate debt |
13.93 |
% |
|
807,985 |
|
|
299,123 |
|
|
508,862 |
|
|
— |
|
Corporate equity |
— |
|
|
106,227 |
|
|
81,810 |
|
|
6,097 |
|
|
18,320 |
|
U.S. sovereign debt |
3.99 |
% |
|
73,787 |
|
|
73,787 |
|
|
— |
|
|
— |
|
Exchange traded notes |
— |
|
|
4,837 |
|
|
2,369 |
|
|
2,468 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total trading securities |
|
|
$ |
2,275,286
|
|
|
$ |
1,444,746
|
|
|
$ |
812,220
|
|
|
$ |
18,320
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-U.S. sovereign debt |
9.96 |
% |
|
208,231 |
|
|
128,772 |
|
|
79,459 |
|
|
— |
|
Corporate debt |
14.81 |
% |
|
243,730 |
|
|
91,537 |
|
|
152,193 |
|
|
— |
|
U.S. sovereign debt |
2.73 |
% |
|
21,626 |
|
|
21,626 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale securities, at fair value |
|
|
$ |
473,587
|
|
|
$ |
241,935
|
|
|
$ |
231,652
|
|
|
$ |
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average
interest rate
|
|
Total |
|
Fair Value Measurements at
March 31, 2024 using
|
|
|
|
Quoted Prices in Active Markets for Identical Assets |
|
Significant Other Observable Inputs |
|
Significant unobservable units |
|
|
|
(Level 1) |
|
(Level 2) |
|
(Level 3) |
|
|
|
|
|
|
|
|
|
|
Non-U.S. sovereign debt |
11.61 |
% |
|
$ |
2,409,126 |
|
|
$ |
1,592,380 |
|
|
$ |
816,746 |
|
|
$ |
— |
|
Corporate debt |
14.83 |
% |
|
1,108,870 |
|
|
171,218 |
|
|
937,360 |
|
|
292 |
|
Corporate equity |
— |
|
|
126,103 |
|
|
102,134 |
|
|
3,819 |
|
|
20,150 |
|
U.S. sovereign debt |
4.98 |
% |
|
43,173 |
|
|
43,173 |
|
|
— |
|
|
— |
|
Exchange traded notes |
— |
|
|
1,348 |
|
|
1,045 |
|
|
303 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total trading securities |
|
|
$ |
3,688,620
|
|
|
$ |
1,909,950
|
|
|
$ |
1,758,228
|
|
|
$ |
20,442
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt |
15.53 |
% |
|
$ |
173,568 |
|
|
$ |
47,135 |
|
|
$ |
126,433 |
|
|
$ |
— |
|
Non-U.S. sovereign debt |
10.48 |
% |
|
27,016 |
|
|
12,378 |
|
|
14,638 |
|
|
— |
|
U.S. sovereign debt |
3.54 |
% |
|
16,037 |
|
|
16,037 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale securities, at fair value |
|
|
$ |
216,621
|
|
|
$ |
75,550
|
|
|
$ |
141,071
|
|
|
$ |
—
|
|
|
Debt securities, held-to-maturity |
The table below presents the amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of held-to-maturity securities as of March 31, 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
|
|
Assets measured at amortized cost |
|
Gross unrecognized holding gains |
|
Gross unrecognized holding losses |
|
Fair value of held-to-maturity |
|
Maturity Date |
|
|
|
|
|
|
|
|
|
|
|
Non-US sovereign debt |
|
65,860 |
|
|
332 |
|
|
(1,240) |
|
|
64,952 |
|
|
2031 - 2037 |
Total held-to-maturity securities |
|
$ |
65,860
|
|
|
$ |
332
|
|
|
$ |
(1,240) |
|
|
$ |
64,952
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of valuation techniques and significant level 3 inputs |
The tables below present the Valuation Techniques and Significant Level 3 inputs used in the valuation as of March 31, 2025 and March 31, 2024. The table is not intended to be all inclusive, but instead captures the significant unobservable inputs relevant to determination of fair value.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Type |
|
Valuation
Technique
|
|
FV as of March 31, 2025 |
|
Significant Unobservable Inputs |
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate equity |
|
DCF |
|
18,193 |
|
|
Discount rate |
|
21.5% |
|
|
|
|
|
|
Estimated number of years |
|
2 years |
|
|
|
|
|
|
Termination multiplier |
|
19.5x |
Corporate equity |
|
DCF |
|
127 |
|
|
Discount rate |
|
58.8% |
|
|
|
|
|
|
Estimated number of years |
|
9 years |
|
|
|
|
$ |
18,320
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Type |
|
Valuation
Technique
|
|
FV as of March 31, 2024 |
|
Significant Unobservable Inputs |
|
% |
|
|
|
|
|
|
|
|
|
Corporate debt |
|
DCF |
|
$ |
292 |
|
|
Discount rate |
|
74.0% |
|
|
|
|
|
|
Estimated number of years |
|
3 months |
Corporate equity |
|
DCF |
|
20,007 |
|
|
Discount rate |
|
13.0% |
|
|
|
|
|
|
Estimated number of years |
|
4 years, 6 months |
|
|
|
|
|
|
Termination multiplier |
|
27x |
Corporate equity |
|
DCF |
|
143 |
|
|
Discount rate |
|
58.8% |
|
|
|
|
|
|
Estimated number of years |
|
9 years |
|
|
|
|
$ |
20,442
|
|
|
|
|
|
The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the years ended March 31, 2025 and March 31, 2024:
|
|
|
|
|
|
|
Trading securities |
Balance as of March 31, 2023 |
$ |
5,138
|
|
|
|
Reclassification to Level 2 |
(32) |
|
Deconsolidation of Freedom UA securities |
(3,927) |
|
Sale of investments that use Level 3 inputs |
(15,856) |
|
Purchase of investments that use Level 3 inputs |
35,807 |
|
Revaluation of investments that use Level 3 inputs |
(132) |
|
Reclassification to investment in associate |
(556) |
|
Balance as of March 31, 2024 |
$ |
20,442
|
|
|
|
|
|
|
|
|
|
|
|
Revaluation of investments that use Level 3 inputs |
(2,122) |
|
|
|
Balance as of March 31, 2025 |
$ |
18,320
|
|
|
Schedule of amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities |
The table below presents the amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities as of March 31, 2025 and 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
|
|
Assets measured at amortized cost |
|
Recognized impairment loss in Income Statement |
|
Unrealized gain/(loss) accumulated in other comprehensive income/(loss) including foreign currency translation adjustments, net |
|
Assets measured at fair value |
|
Maturity Date |
|
|
|
|
|
|
|
|
|
|
|
Non-US sovereign debt |
|
211,628 |
|
|
(378) |
|
|
(3,019) |
|
|
208,231 |
|
|
2025 - indefinite |
Corporate debt |
|
$ |
243,660 |
|
|
$ |
(28) |
|
|
$ |
98 |
|
|
$ |
243,730 |
|
|
2025 - 2039 |
U.S. sovereign debt |
|
21,868 |
|
|
— |
|
|
(242) |
|
|
21,626 |
|
|
2027 - 2044 |
Total available-for-sale securities, at fair value |
|
$ |
477,156
|
|
|
$ |
(406) |
|
|
$ |
(3,163) |
|
|
$ |
473,587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
|
Assets measured at amortized cost |
|
Recognized impairment loss in Income Statement |
|
Unrealized loss accumulated in other comprehensive income/(loss) including foreign currency translation adjustments, net |
|
Assets measured at fair value |
|
Maturity Date |
|
|
|
|
|
|
|
|
|
|
|
Corporate debt |
|
$ |
172,689 |
|
|
$ |
(61) |
|
|
$ |
940 |
|
|
$ |
173,568 |
|
|
2024 - 2039 |
Non-US sovereign debt |
|
29,121 |
|
|
(352) |
|
|
(1,753) |
|
|
27,016 |
|
|
2024 - indefinite |
U.S. sovereign debt |
|
16,767 |
|
|
— |
|
|
(730) |
|
|
16,037 |
|
|
2027 - 2044 |
Total available-for-sale securities, at fair value |
|
$ |
218,577
|
|
|
$ |
(413) |
|
|
$ |
(1,543) |
|
|
$ |
216,621
|
|
|
|
|